Circassia Limited

CIRCASSIA

Pharmaceutical preparations for the testing, diagnosis and treatment of allergies, autoimmune disease, transplant rejection and immunodeficiency disorders; diagnostic and testing reagents for testing and diagnosing medical and veterinary conditions; vaccines;Scientific research for medical purposes in the fields of allergy treatment, prevention, and cures; medical and pharmacological research services; research and development of allergy treatments, vaccines, medicines, and new products for others in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the fields of pharmaceutical and clinical trials; information, advisory and consultancy services relating to the aforesaid;

CIRCASSIA

The mark consists of the stylized wording CIRCASSIA to the right of a design of seven shaded small diamond designs arranged into two larger overlapping diamond shapes.;Computer hardware and recorded software sold as a unit for diagnosing, monitoring, measuring, calculating, analysing and displaying airway inflammation and respiratory status; computer hardware and recorded software sold as a unit for analysing, storing, organising, categorising, tracking, displaying and retrieving data regarding airway inflammation and respiratory status; computer hardware and recorded software sold as a unit for analysing, storing, organising, categorising, tracking, displaying and retrieving data from medical devices;Medical apparatus for sampling of gases in human organs and for control of pulmonary functionality; medical devices for controlling the exhalation of oxygen in breath; medical devices being containers for the storage of exhaled breath samples; medical devices, namely, respiratory filters and nozzles for use in sampling exhalation; medical devices, namely, containers for sampling and storing of medical gas tests;